Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Capricor rapeutics

Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022

Upgrades

Benzinga · Oct 26, 2022

More Than $27 Million Bet On Seres Therapeutics? 4 Penny Stocks Insiders are Buying

U.S. stock futures traded lower this morning on Friday ahead of jobs report for june. Investors, meanwhile, focused on some notable insider trades.

Benzinga · Jul 8, 2022

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga · Mar 28, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Earnings Outlook For Capricor Therapeutics

Capricor Therapeutics (NASDAQ:CAPR) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts estimate that Capricor Therapeutics will report an earnings per share (EPS) of $-0.19.

Benzinga · Mar 9, 2022

Coverage From

Benzinga

Organisations

Regeneron Pharmaceuticals

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Jobs Report

507 stories

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.